Chanelle Pharma, a global pharmaceutical leader in human and animal health, today announced a strategic partnership with SAP SE (NYSE: SAP) to implement SAP S/4HANA Cloud (private edition) and SAP Business AI. This initiative represents a major investment in building a modern, scalable digital foundation designed to accelerate time-to-market for innovative medicines, elevate operational visibility, and proactively enhance data governance.

Currently exporting to over 90 countries with expansive operations across Ireland, the UK, Portugal, and Jordan, Chanelle Pharma is positioned for continued international growth. To support this ambitious trajectory, the company is modernising its end-to-end operational value chain.

By establishing a robust digital core, Chanelle Pharma will meet higher expectations for GxP regulatory compliance while modernising core finance, manufacturing and supply chain processes.

Delivered as a single-phase programme, with a targeted go-live of late 2026, the transformation is being delivered jointly by Tenthpin and KaarTech. The implementation strategy is strategically sequenced. Chanelle Pharma will deploy SAP’s ERP platform first to establish a “clean core” leveraging SAP best practices, immediately paving the way for the integration of advanced SAP Business AI capabilities.

The transformation will leverage Tenthpin’s sophisticated SAP Signavio processes, which are uniquely optimised for Contract Development and Manufacturing Organisations (CDMOs), ensuring a seamless, high-velocity implementation that maximises strategic value.

Aiden Dempsey, CIO, Chanelle Pharma, said, “This strategic partnership with SAP marks a pivotal moment in our growth trajectory. We are investing heavily in a scalable digital foundation that will accelerate our time-to-market and drive global manufacturing excellence. SAP S/4HANA Cloud and Business AI give us the competitive advantage to pioneer the future of the pharmaceutical industry while maintaining the highest standards of GxP compliance.”

Ray Joyce, Head of Ireland, SAP UK&I, said, “Pharmaceutical organisations are operating in an increasingly complex environment, where regulation, supply chains and demand can all shift quickly. SAP’s Cloud ERP strengthens organisational resilience and governance processes and provides data insights from across the business. This empowers Chanelle Pharma to operate with agility and remain competitive in a highly regulated global market.”.

Simon Flowers, Partner, Tenthpin, said, “Collaborating with Chanelle Pharma and KaarTech on this single-phase transformation allows us to deliver unparalleled value to an industry leader. By utilising Tenthpin’s SAP Signavio processes, we are enabling Chanelle Pharma to seamlessly integrate SAP best practices. This helps Chanelle Pharma navigate operational and regulatory complexity with greater certainty supported by a resilient SAP digital backbone that can evolve with whatever comes next.”